At what enterprise value was IMV TECHNOLOGIES acquired in 2021?

During the acquisition of IMV TECHNOLOGIES by MONTAGU PRIVATE EQUITY in 2021, the company was valued at an estimated revenue multiple of below 5x. The transaction's Enterprise Value is estimated to be in the range of 300M - 700M EUR. By registering for free, you get access to complete and exact transaction details including enterprise value, revenue, and EBITDA. Additionally, our database shows that the Healthcare & Pharma industry currently tracks an average EBITDA multiple of 14.4x, providing a valuable benchmark for this transaction.

What was the EV/EBITDA of IMV TECHNOLOGIES when it was acquired by MONTAGU PRIVATE EQUITY?

The estimated EV/EBITDA multiple for IMV TECHNOLOGIES is in the range of 10x - 18x. For comparison, the Healthcare & Pharma sector currently shows an average EBITDA multiple of 14.4x. Join our community for free to access full valuation data and industry trends.

When was IMV TECHNOLOGIES acquired by MONTAGU PRIVATE EQUITY?

IMV TECHNOLOGIES was acquired by MONTAGU PRIVATE EQUITY in 2021.

What was the revenue of IMV TECHNOLOGIES at the time of the deal?

The revenue of IMV TECHNOLOGIES at the time of the deal is estimated to be in the range of 100M - 200M EUR. Register for free to access the full transaction report and exact valuation multiples.

What was the EBITDA of IMV TECHNOLOGIES during the acquisition?

IMV TECHNOLOGIES's EBITDA is estimated to be in the range of 10M - 30M EUR. Join our community for free to access complete and exact deal data.

What is Enterprise Value (EV)?

Enterprise Value (EV) is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. EV includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

What is the EV/EBITDA multiple and why is it used?

The EV/EBITDA multiple is a financial ratio that compares a company's Enterprise Value (EV) to its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA). It is widely used in M&A and valuation because it allows for comparisons between companies with different capital structures and provides a clear view of operational profitability.

How is the data for the IMV TECHNOLOGIES acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the IMV TECHNOLOGIES deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://montagu.com/montagu-enters-exclusive-negotiations-to-acquire-imv-technologies/

← DATABASE

Home Database Healthcare & PharmaIMV TECHNOLOGIES

01/2021

IMV TECHNOLOGIES acquired by MONTAGU PRIVATE EQUITY

FRANCE Life Sciences / Pharma & Biotech / R&D Biotech EV 300M - 700M EUR

Context

Montagu Private Equity entered into exclusive negotiations to acquire a majority stake in IMV Technologies from Qualium Investissement. Montagu prevailed in a competitive process against CVC Capital Partners. This transaction marks the fifth LBO for the company, which was previously backed by Idi, Ofi Private Equity, and Sparring Capital. The deal underpins the company's leadership in the niche market of animal genetics and its strong export capabilities.

As a reminder, the company has already undergone several LBOs, notably with Sparring Capital in 2010 and Qualium in 2014. This succession of buyouts highlights the high attractiveness of the company's business model.

IMV TECHNOLOGIES, which reported an EBITDA margin of LOGIN in 2020, is valued in this transaction at an EV/EBITDA multiple of LOGIN, representing a LOGIN to the average currently observed in the Healthcare & Pharma sector (14.4x).

Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.

-> Deep-dive in Healthcare & Pharma market trends

Target

IMV Technologies is the world leader in reproduction biotechnologies for livestock (primarily bovine and porcine). The company designs and manufactures equipment and consumables (plastic straws) for artificial insemination. It holds a dominant position with over 50% global market share in bovine packaging. 85% of its revenue is generated internationally across 120 countries.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (EUR)

Year

Rev

EBITDA

EBIT

2020

2019

Other operations with IMV TECHNOLOGIES

List of similar M&A transactions (Date, Acquirer, Target, Country, Sector, Deal Context)
Date	Acquirer	Target	Country	Sector	Deal Context
11/2014	QUALIUM	IMV TECHNOLOGIES	FRANCE	Life Sciences	Qualium Investissement won the auction process to acquire IMV Technologies, beating competitors LBO France and Florac. This transaction ends the tenure of Pragma Capital (majority owner since 2010), as well as minority investors Cathay Capital and Eurazeo PME. The acquisition is supported by a unitranche debt facility provided by Ardian, representing a leverage of over 5.0x EBITDA. The strategic focus remains on international expansion.
09/2010	SPARRING CAPITAL	IMV TECHNOLOGIES	FRANCE	Life Sciences	OFI Private Equity Capital announced the sale of its majority stake in IMV Technologies to Pragma Capital (Renamed Sparring Capital). OFI PE retains a minority stake of 11% by reinvesting EUR5 million alongside the management team led. The transaction concludes a 3-year holding period during which the company accelerated its external growth and opened a new industrial site.

REFERENCES

Valuation range: EV 300M - 700M EUR

Revenue range: 100M - 200M EUR

EBITDA range: 10M - 30M EUR

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of IMV TECHNOLOGIES by MONTAGU PRIVATE EQUITY are reserved for mynth community members. Register for free to unlock full data.

Authors: verified mynth contributor (mynth data is contributed by M&A / PE professionals and systematically cross-verified with private deal documents and official press releases).

Press release: view release

Target: imv technologies

Acquirer: montagu private equity